Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
|
|
CATALYST PHARMACEUTICALS, INC. (CPRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2013 |
8-K
| Investor presentation|
Docs:
|
"Information posted on Company's website on February 11, 2013",
"Catalyst Pharmaceutical Partners Provides Update on Research and Development Pipeline CORAL GABLES, FL - February 11, 2013 — Catalyst Pharmaceutical Partners, Inc. , a specialty pharmaceutical company focused on the development and commercialization of novel prescription drugs targeting rare neurological diseases and disorders, today provided an update on its research and development pipeline. “We are providing this information today to update our shareholders, patients, physicians, key opinion leaders and the financial community on our drug development activities. We are primarily focused on rapidly advancing the development of Firdapse TM for the treatment of Lambert-Eaton Myasthenic Syndrome , which is our lead product candidate,” said Patrick J. McEnany, Chief Executive Officer of Cata..." |
|
|
|